These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10355530)

  • 1. Expression of bcl-2 protein in non-small cell lung cancer: correlation with clinicopathology and patient survival.
    Laudanski J; Chyczewski L; Niklińska WE; Kretowska M; Furman M; Sawicki B; Nikliński J
    Neoplasma; 1999; 46(1):25-30. PubMed ID: 10355530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 protein expression correlates with better prognosis in patients with advanced non-small cell lung cancer.
    Shibata Y; Hidaka S; Tagawa Y; Nagayasu T
    Anticancer Res; 2004; 24(3b):1925-8. PubMed ID: 15274378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of bcl-2 protein is associated with shorter survival in nonsmall cell lung carcinoma.
    Huang CI; Neuberg D; Johnson BE; Wei JY; Christiani DC
    Cancer; 2003 Jul; 98(1):135-43. PubMed ID: 12833466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
    Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
    Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
    Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
    Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
    Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F; Dosaka-Akita H; Mishina T; Nishi M; Kojima T; Hiroumi H; Ogura S; Shimizu M; Katoh H; Kawakami Y
    Clin Cancer Res; 2000 Oct; 6(10):4073-81. PubMed ID: 11051259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients.
    Ferreira CG; van der Valk P; Span SW; Ludwig I; Smit EF; Kruyt FA; Pinedo HM; van Tinteren H; Giaccone G
    Clin Cancer Res; 2001 Aug; 7(8):2468-74. PubMed ID: 11489828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization.
    Boldrini L; Calcinai A; Samaritani E; Pistolesi F; Mussi A; Lucchi M; Angeletti CA; Basolo F; Fontanini G
    Br J Cancer; 2000 Aug; 83(4):480-6. PubMed ID: 10945495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of Bcl-2 gene expression and its prognostic value in non-small cell lung cancer.
    Yilmaz A; Savaş I; Dizbay Sak S; Güngör A; Kaya A; Serinsöz E; Savaş B
    Tuberk Toraks; 2005; 53(4):323-9. PubMed ID: 16456730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. bcl-2 protein in non-small-cell lung carcinoma.
    Pezzella F; Turley H; Kuzu I; Tungekar MF; Dunnill MS; Pierce CB; Harris A; Gatter KC; Mason DY
    N Engl J Med; 1993 Sep; 329(10):690-4. PubMed ID: 8393963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
    Ludovini V; Gregorc V; Pistola L; Mihaylova Z; Floriani I; Darwish S; Stracci F; Tofanetti FR; Ferraldeschi M; Di Carlo L; Ragusa M; Daddi G; Tonato M
    Lung Cancer; 2004 Oct; 46(1):77-85. PubMed ID: 15364135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
    Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic value of expression of FASE, HER-2/neu, bcl-2 and p53 in stage I non-small cell lung cancer].
    Wang Y; Zhang XR; Fu J; Tan W; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):369-72. PubMed ID: 15312350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. bcl-2 and p53 protein expression in non-small cell lung cancers: correlation with survival time.
    Ohsaki Y; Toyoshima E; Fujiuchi S; Matsui H; Hirata S; Miyokawa N; Kubo Y; Kikuchi K
    Clin Cancer Res; 1996 May; 2(5):915-20. PubMed ID: 9816250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
    Ishikawa S; Nakagawa T; Miyahara R; Kawano Y; Takenaka K; Yanagihara K; Otake Y; Katakura H; Wada H; Tanaka F
    Clin Cancer Res; 2005 Feb; 11(3):1198-202. PubMed ID: 15709189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of pRb2/p130 expression is associated with unfavorable clinical outcome in lung cancer.
    Caputi M; Groeger AM; Esposito V; De Luca A; Masciullo V; Mancini A; Baldi F; Wolner E; Giordano A
    Clin Cancer Res; 2002 Dec; 8(12):3850-6. PubMed ID: 12473599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2 expression as an apoptotic index in non small cell lung carcinomas.
    Kalogeraki A; Kozoni V; Zoras O; Tamiolakis D; Panayiotides J; Charakidas A; Chalkiadakis G; Bouros D; Stathopoulos E; Delides GS
    In Vivo; 2001; 15(1):53-6. PubMed ID: 11286130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.